Tissue plasminogen activator gene expression in multiple sclerosis brain tissue

被引:25
作者
Akenami, FOT
Sirén, V
Wessman, M
Koskiniemi, M
Vaheri, A
机构
[1] Univ Helsinki, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Dept Biosci, Div Genet, FIN-00014 Helsinki, Finland
关键词
multiple sclerosis; tPA; mRNA; brain tissue; tPA immunohistochemistry; neurological disease;
D O I
10.1016/S0022-510X(99)00080-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent studies have implicated tissue-type plasminogen activator (tPA) in neurodegeneration. We studied multiple sclerosis (MS) brain tissue for tPA gene and protein expression in comparison with reference tissue, by in situ hybridisation and immunohistochemistry. MS is characterised by demyelination in the central nervous system. In this study, neuronal cell bodies in MS brain showed high expression of tPA mRNA and protein, while in reference brains, staining for protein and mRNA expression were very low in neurons and mostly restricted to blood vessel walls. In MS, there was an additional staining of mononuclear cells within perivascular cuffs and foamy macrophages within demyelinating plaques. In view of evidence that the final process of demyelination in MS is thought to be enzyme-mediated, our work suggests the involvement of tPA and by inference plasmin, in the demyelinating process. Blocking tPA or plasmin activity may be a potentially beneficial therapeutic approach in MS. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 36 条
[1]   Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease [J].
Akenami, FOT ;
Koskiniemi, M ;
Farkkila, M ;
Vaheri, A .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (02) :157-160
[2]   Plasma and cerebrospinal fluid activities of tissue plasminogen activator, urokinase and plasminogen activator inhibitor-1 in multiple sclerosis [J].
Akenami, FOT ;
Koskiniemi, M ;
Mustjoki, S ;
Siren, V ;
Farkkila, M ;
Vaheri, A .
FIBRINOLYSIS & PROTEOLYSIS, 1997, 11 (02) :109-113
[3]   Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases [J].
Akenami, FOT ;
Siren, V ;
Koskiniemi, M ;
Siimes, MA ;
Teravainen, H ;
Vaheri, A .
JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (07) :577-580
[4]  
AKENAMI FOT, 1999, IN PRESS FRIBONOLYSI
[5]  
CARROLL PM, 1994, DEVELOPMENT, V120, P3173
[6]   Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin [J].
Chen, ZL ;
Strickland, S .
CELL, 1997, 91 (07) :917-925
[7]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[8]   The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution [J].
Cuzner, ML ;
Gveric, D ;
Strand, C ;
Loughlin, AJ ;
Paemen, L ;
Opdenakker, G ;
Newcombe, J .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (12) :1194-1204
[9]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[10]   EXPRESSION OF MONOCYTE ACTIVATION ANTIGEN MO3 ON THE SURFACE OF PERIPHERAL-BLOOD MONOCYTES FROM PATIENTS WITH MULTIPLE-SCLEROSIS [J].
DOREDUFFY, P ;
DONOVAN, C ;
TODD, RF .
NEUROLOGY, 1992, 42 (08) :1609-1614